Tilray Backs First Human Study On Medical Marijuana Used For Breast Cancer Drug Side Effects

Benzinga

•

October 24th, 2019

DESCRIPTION

Tilray, Inc. (NASDAQ: TLRY) announced Thursday it has imported medical cannabis into the U.S. from Canada to back a new clinical trial.

Benzinga

Benzinga delivers fast, actionable financial news and market insights to help investors stay ahead of the curve. From breaking market headlines and earnings coverage to expert analysis on stocks, options, futures, crypto, and macro trends, Benzinga connects audiences with the information that moves markets. Our video content features real-time market commentary, educational segments, and exclusive interviews with industry leaders—designed for active traders, long-term investors, and anyone looking to better understand the financial landscape.